Thrombolytic Therapy per Protocol โ Indicated
โจ The client has an acute ST-elevation myocardial infarction (STEMI) with ST elevation in V3 and V4.
โจ His symptoms began approximately 2 hours ago, placing him within the potential treatment window for fibrinolytic therapy when timely PCI is unavailable.
โจ Thrombolytic medications dissolve the coronary thrombus responsible for acute coronary artery occlusion.
โจ Restoring coronary blood flow limits the amount of irreversible myocardial necrosis.
โจ The markedly elevated troponin T and CK-MB further support acute myocardial injury.
โจ The client must first be screened carefully for contraindications to fibrinolytic therapy, particularly active bleeding and prior intracranial hemorrhage.
โจ Reperfusion should occur as rapidly as possible because prolonged coronary occlusion results in increasing myocardial damage.
โจ Therefore, thrombolytic therapy per protocol is indicated if PCI cannot be provided within the recommended timeframe and no contraindications exist.
Aspirin 325 mg PO โ Indicated
โจ Aspirin inhibits platelet aggregation and helps prevent further enlargement of the coronary thrombus.
โจ Aspirin is an important early medication in the management of suspected acute myocardial infarction when no contraindication exists.
โจ The client's STEMI is most likely associated with acute coronary thrombosis following atherosclerotic plaque disruption.
โจ Reducing platelet aggregation helps limit additional coronary artery occlusion.
โจ Aspirin should generally be administered promptly because early antiplatelet therapy improves outcomes in acute coronary syndromes.
โจ A dose in the range represented by 325 mg is appropriate for initial acute treatment according to common ACS protocols.
โจ The nurse should verify that the client does not have an aspirin allergy or another major contraindication.
โจ Therefore, aspirin is clearly indicated for this client's acute STEMI.
Insert IV โ Indicated
โจ Reliable intravenous access is essential for a client experiencing an acute STEMI.
โจ IV access permits rapid administration of medications such as nitroglycerin and morphine when clinically appropriate.
โจ It also provides immediate access if the client develops a life-threatening dysrhythmia or hemodynamic instability.
โจ Acute MI can deteriorate rapidly into cardiogenic shock, cardiac arrest, or other serious complications.
โจ IV access is also necessary for many medications used during emergency reperfusion management.
โจ The client's current condition requires continuous monitoring and readiness for emergency treatment.
โจ Establishing vascular access should therefore occur early during emergency stabilization.
โจ The order to insert an IV is indicated.
Digoxin 0.25 mcg PO โ Not Indicated
โจ Digoxin is primarily used for selected clients with heart failure or certain supraventricular dysrhythmias such as atrial fibrillation.
โจ The client has sinus rhythm and no documented indication requiring digoxin therapy.
โจ Digoxin does not restore blood flow through an acutely occluded coronary artery.
Q1HR Complete Neurological Checks โ Indicated
โจ Frequent neurological assessments are particularly important when a client receives thrombolytic therapy because intracranial hemorrhage is a serious potential complication.
โจ The nurse should establish and monitor the client's level of consciousness and neurological status.
โจ New confusion, decreased consciousness, severe headache, weakness, or speech changes can indicate intracranial bleeding.
โจ Early identification of neurological deterioration allows rapid intervention and evaluation.
โจ Thrombolytic therapy increases bleeding risk because it promotes breakdown of fibrin-containing clots.
โจ Neurological monitoring therefore becomes an important component of the client's safety surveillance following fibrinolytic administration.
โจ The client's baseline neurological status is currently alert and oriented ร3, providing a useful comparison for subsequent assessments.
โจ Therefore, scheduled complete neurological checks are indicated in this treatment plan.
Metoprolol 50 mg PO โ Indicated
โจ Metoprolol is a betaโ-adrenergic blocker that reduces heart rate, blood pressure, and myocardial contractility.
โจ These effects decrease myocardial oxygen demand, which can be beneficial during acute myocardial ischemia.
โจ The client has a blood pressure of 162/89 mm Hg, so hypotension is not currently present.
โจ His heart rate of 99/min also does not indicate bradycardia.
โจ Beta-blockers may reduce recurrent ischemia and certain cardiac complications when appropriately used after acute MI.
โจ The nurse should monitor for bradycardia, hypotension, heart block, and signs of heart failure.
โจ The client's history of asthma warrants additional caution because beta-blockers can potentially contribute to bronchospasm, although metoprolol is relatively betaโ-selective.
โจ Therefore, metoprolol is indicated with appropriate assessment and monitoring.
Nitroglycerin Infusion โ Indicated
โจ Nitroglycerin causes vasodilation and can reduce myocardial oxygen demand and ischemic chest discomfort.
โจ This client continues to experience severe 8/10 crushing chest pain, making anti-ischemic treatment appropriate.
โจ His blood pressure of 162/89 mm Hg provides adequate pressure for cautious nitrate administration.
โจ The infusion can be titrated according to the client's pain response and blood pressure.
โจ Nitroglycerin reduces preload through venodilation and can decrease cardiac workload.
โจ The nurse must monitor carefully for hypotension and headache during treatment.
โจ Recent use of a phosphodiesterase-5 inhibitor would be an important contraindication that must be assessed before nitrate administration.
โจ Therefore, titrated IV nitroglycerin is indicated for this client's ongoing ischemic symptoms.
Oxygen Therapy โ Indicated
โจ The client's oxygen saturation is 90% on room air, demonstrating hypoxemia.
โจ Supplemental oxygen is appropriate during acute MI when oxygen saturation is reduced.
โจ The order specifically directs oxygen administration to maintain saturation above 92%.
โจ Adequate oxygenation supports oxygen delivery to the ischemic myocardium and other vital organs.
โจ The client also reports shortness of breath, further supporting the need for oxygen therapy.
โจ Oxygen saturation should be continuously reassessed and therapy adjusted according to the client's response.
โจ Routine oxygen is unnecessary in adequately oxygenated MI patients, but this client's saturation is clearly below the prescribed target.
โจ Therefore, supplemental oxygen is indicated.
Morphine 0.5 mg IV โ Indicated
โจ Morphine may be used cautiously for severe ischemic chest pain that persists despite appropriate anti-ischemic therapy.
โจ This client reports severe 8/10 chest pain, indicating substantial ongoing discomfort.
โจ Morphine provides analgesia and can decrease sympathetic activation associated with severe pain and anxiety.
โจ Reduced sympathetic activity can decrease cardiac workload and myocardial oxygen demand.
โจ IV administration allows rapid onset and careful titration of the medication's effects.
โจ The nurse must monitor blood pressure, respiratory rate, level of consciousness, and oxygen saturation after administration.
โจ Current ACS practice generally reserves morphine for persistent severe pain rather than administering it routinely to every MI patient.
โจ Given the prescribed dose and severe persistent pain, morphine is indicated with careful monitoring.
Cephalexin 500 mg PO โ Not Indicated
โจ Cephalexin is an antibiotic used to treat susceptible bacterial infections.
โจ The client has no findings suggesting an active bacterial infection, and his WBC count is normal at 9,000/mmยณ.
โจ Antibiotic therapy does not treat the coronary occlusion responsible for this client's acute STEMI.
